| Identification | Back Directory | [Name]
(2S,3S,4R,5R)-2-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-5-{6-[(4-chloro-2-fluorophenyl)amino]-9H-purin-9-yl}oxolane-3,4-diol | [CAS]
253124-46-8 | [Synonyms]
GW493838
GW-493838
GW493838X
GW 493838
GW 493838X
GW-493838X
(2S,3S,4R,5R)-2-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-5-{6-[(4-chloro-2-fluorophenyl)amino]-9H-purin-9-yl}oxolane-3,4-diol | [EINECS(EC#)]
689-185-2 | [Molecular Formula]
C21H21ClFN7O4 | [MOL File]
253124-46-8.mol | [Molecular Weight]
489.887 |
| Hazard Information | Back Directory | [Uses]
GW-493838 is a potent Adenosine A1 (A1AR) agonist. GW-493838 has the potential for the research of neuropathic pain[1]. | [IC 50]
A1AR | [References]
[1] Rizzolio F, et al. Adenosine receptor ligands in clinical trials. Curr Top Med Chem. 2010;10(10):1036-45. DOI:10.2174/156802610791293154 |
|
|